Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.5698
-0.0116
(-2.00%)
At close: April 4 at 4:00:01 PM EDT
0.5790
+0.01
+(1.61%)
After hours: April 4 at 7:52:21 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | -- | -- |
Avg. Estimate | -0.05 | -0.05 | 0 | 0 |
Low Estimate | -0.05 | -0.05 | 0 | 0 |
High Estimate | -0.05 | -0.05 | 0 | 0 |
Year Ago EPS | -0.07 | -0.08 | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 3 | 4 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | 4.14M | 3.95M | 16.89M | -- |
Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.07 | -0.06 | -0.08 | -0.08 |
EPS Actual | -0.07 | -0.08 | -0.05 | -0.07 |
Difference | 0 | -0.02 | 0.03 | 0.01 |
Surprise % | 0.00% | -26.67% | 35.00% | 10.87% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.05 | -0.05 | 0 | 0 |
7 Days Ago | -0.05 | -0.05 | 0 | 0 |
30 Days Ago | -0.05 | -0.05 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
VERU | 28.57% | 34.21% | -- | -- |
S&P 500 | 6.57% | 6.54% | 9.73% | 14.28% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 1/2/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 12/20/2024 |
Reiterates | Oppenheimer: Outperform to Outperform | 11/5/2024 |
Initiated | B. Riley Securities: Buy | 5/14/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 5/6/2024 |
Related Tickers
HEPA Hepion Pharmaceuticals, Inc.
0.4601
-4.90%
IBO Impact BioMedical Inc.
0.9627
+107.48%
TCRT Alaunos Therapeutics, Inc.
2.9500
-30.09%
QNRX Quoin Pharmaceuticals, Ltd.
0.2332
-10.34%
GRI GRI Bio, Inc.
1.5100
+4.86%
APVO Aptevo Therapeutics Inc.
1.4900
-25.13%
PTIX Protagenic Therapeutics, Inc.
0.3876
-7.27%
SGMO Sangamo Therapeutics, Inc.
0.6565
+5.50%
OSRH OSR Holdings, Inc.
1.9500
-21.05%
CMPX Compass Therapeutics, Inc.
1.4600
-9.03%